Acelrx Pharmaceuticals Inc

+0.01 (+0.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)135.77M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.06 Million
Adjusted EPS-$0.08
See more estimates
10-Day MA$1.21
50-Day MA$1.56
200-Day MA$1.58
See more pivots

Acelrx Pharmaceuticals Inc Stock, NASDAQ:ACRX

351 Galveston Drive, Redwood City, California 94063
United States of America
Phone: +1.650.216.3500
Number of Employees: 54


AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.